下肢血运重建的杂交手术:单中心真实世界经验
该单中心回顾性研究纳入2012–2017年81例(89条肢体)多节段下肢动脉闭塞性疾病患者,行杂交血运重建,中位随访10.7个月。慢性肢体威胁性缺血占80.9%;1年一期、一期辅助及二期通畅率分别为78.28%、85.12%、90.19%,大截肢率14.6%,死亡率16.0%。多节段TASC C/D与临床改善降低和截肢率升高相关。
要点
- 杂交手术可用于多节段下肢动脉闭塞,尤其慢性肢体威胁性缺血患者。
- 1年一期通畅率78.28%,二期通畅率90.19%,大截肢率14.6%。
- 多节段TASC C/D与临床改善降低及截肢率升高独立相关。
核心结论
- 杂交下肢血运重建对复杂动脉病变患者是潜在可行方法,可使患者受益于创伤较小的手术。
研究设计与样本
- 单中心回顾性研究,收集2012–2017年择期杂交下肢血运重建手术数据。
- 共81例患者、89条肢体,中位年龄69岁(IQR 61–73),中位随访10.7个月(IQR 2.5–25.1)。
主要发现
- 治疗指征为慢性肢体威胁性缺血者占80.9%,其中静息痛18.0%、组织缺损62.9%。
- 1年一期、一期辅助、二期通畅率分别为78.28%(95%CI 65.20–86.92)、85.12%(95%CI 72.96–92.09)、90.19%(95%CI 79.13–95.54)。
- 总体分类临床改善率为56.2%,大截肢率为14.6%,死亡率为16.0%。
- 多节段TASC C或D与临床改善降低独立相关(aOR 0.08,P<0.0001),Leriche-Fontaine IV期亦相关(aOR 0.25,P=0.013)。
- 多节段TASC C或D与更高截肢率相关(aHR 11.37,P=0.002),临床分期与截肢率关系无统计学意义(aHR 4.70,P=0.091)。
关键数值与推荐
- 多节段TASC C或D:临床改善aOR 0.08(P<0.0001),大截肢aHR 11.37(P=0.002)。
- Leriche-Fontaine IV期:临床改善aOR 0.25(P=0.013)。
- 一期辅助通畅与临床改善aOR 4.30(P=0.036)、大截肢aHR 0.11(P=0.003)相关。
- 二期通畅与临床改善aOR 7.36(P=0.021)、大截肢aHR 0.09(P=0.001)相关。
临床怎么用
- 对多节段下肢动脉闭塞患者,杂交手术可作为减少开放手术创伤的候选策略。
- 术前评估TASC分型和Leriche-Fontaine分期有助于预判临床改善与截肢风险。
- 术后应重视通畅率监测,一期辅助或二期通畅与更好的临床改善和更低截肢率相关。
局限性
- 单中心回顾性设计,样本量有限(81例/89条肢体)。
- 中位随访10.7个月,中长期结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Through the association of endovascular and open procedures, hybrid surgery for lower limb revascularization allows the treatment of multilevel occlusive disease with a lower risk when compared to extensive open interventions. The aim of this study is to evaluate the immediate and midterm clinical outcomes of hybrid techniques for lower limb revascularization in a cohort of patients with multilevel arterial disease. METHODS: Data from elective procedures between 2012 and 2017 were retrospectively collected regarding hybrid lower limb revascularization procedures. The outcomes of the study were categorical clinical improvement, patency rates, major amputation rates, and mortality. RESULTS: A total of 81 patients, 89 limbs, with a median age of 69 years (interquartile range [IQR] 61-73) were submitted to hybrid lower limb revascularization, with a median follow-up of 10.7 months (IQR 2.5-25.1). Treatment indications were chronic limb-threatening ischemia in 80.9% of the cases (rest pain in 18.0% and tissue loss in 62.9%). One-year primary, primary-assisted, and secondary patency rates were 78.28% (95% confidence interval [CI] 65.20-86.92), 85.12% (95% CI 72.96-92.09), and 90.19% (95% CI 79.13-95.54), respectively. Overall categorical clinical improvement was observed in 56.2%. Major amputation and mortality rates were 14.6% and 16.0%, respectively. Multilevel Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC) C or D and stage IV Leriche-Fontaine classification were strongly associated with decreased categorical clinical improvement (adjusted odds ratio [aOR] 0.08, P < 0.0001 and aOR 0.25, P = 0.013, respectively). Multilevel TASC C or D was also related to higher amputation rates, contrary to clinical presentation (adjusted hazard ratio [aHR] 11.37, P = 0.002 and aHR 4.70, P = 0.091, respectively). Primary-assisted and secondary patency rates were associated with higher categorical clinical improvement (aOR 4.30, P = 0.036 and aOR 7.36, P = 0.021, respectively) and decreased major amputation rates (aHR 0.11, P = 0.003 and aHR 0.09, P = 0.001, respectively) but were not related to multilevel TASC and Leriche-Fontaine classifications. CONCLUSIONS: The present study reports a real-world experience with a large proportion of patients with chronic limb-threatening ischemia. Hybrid interventions for lower limb revascularization revealed to be a potential approach for patients with complex arterial disease that would beneficiate from less invasive procedures.
引用
- Soares TR, Manuel V, Amorim P, et al. Hybrid Surgery in Lower Limb Revascularization: A Real-World Experience from a Single Center. Ann Vasc Surg. 2019. PMID: 31200057. doi:10.1016/j.avsg.2019.03.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。